Company: KEQU
Filing Date: 2025-03-14
Form Type: 10-Q
Source: 0000055529-25-000013
Chunk: 14

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-03-14
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
Item 1.    Condensed Consolidated Financial Statements

Kewaunee Scientific Corporation

Condensed Consolidated Statements of Operations

(Unaudited)

($ and shares in thousands, except per share amounts)

 Three Months EndedJanuary 31,Nine Months EndedJanuary 31, 2025202420252024Net sales$67,167 $46,778 $163,324 $147,053 Cost of products sold48,788 34,749 118,505 109,642 Gross profit18,379 12,029 44,819 37,411 Operating expenses16,129 8,223 35,560 24,688 Operating profit2,250 3,806 9,259 12,723 Pension expense— (41)— (122)Other income, net162 161 428 384 Interest expense(1,137)(411)(2,051)(1,213)Profit before income taxes1,275 3,515 7,636 11,772 Income tax (benefit) expense(108)982 1,000 3,894 Net earnings1,383 2,533 6,636 7,878 Less: Net earnings attributable to the non-controlling interest29 12 81 151 Net earnings attributable to Kewaunee Scientific Corporation$1,354 $2,521 $6,555 $7,727 Net earnings per share attributable to Kewaunee Scientific Corporation stockholdersBasic$0.47 $0.87 $2.29 $2.68 Diluted$0.45 $0.85 $2.20 $2.64 Weighted average number of common shares outstandingBasic2,872 2,893 2,864 2,885 Diluted2,995 2,965 2,979 2,927 

See accompanying notes to Condensed Consolidated Financial Statements.

1

Kewaunee Scientific Corporation

Condensed Consolidated Statements of Comprehensive Earnings

(Unaudited)

($ in thousands)

 Three Months EndedJanuary 31,Nine Months EndedJanuary 31, 2025202420252024Net earnings$1,383 $2,533 $6,636 $7,878 Other comprehensive loss, net of tax:Foreign currency translation adjustments(